Abstract:The human cytomegalovirus(HCMV)is a member of the herpesvirusfamily infecting 40%～80% of the general population.HCMV can cause fatal infections in immunocompromised individuals.HCMV encodes a serine protease that is essential for viral replication and is a potential target for antiviral drug development.In this paper a peptidomimetic library Ⅰ for HCMV protease inhibitor was designed based on the interactions between the protease active site and its peptidomimetic inhibitors.The library was synthesized in the manner of liquid-phase combinatorial synthesis,by a two-step strategy.Firstly by the Ugi four-component condensation reaction,from four kinds of building blocks-carboxylic acids,amines,aldehydes or ketones and isocyanides,then followed by oxidation of the product Ⅱ to form the library.The isocyanide Ⅲ was the most important block for building up the library.The syntheses of the former compounds Ⅳ of the isocyanides were described.Tartaric acid diamides Ⅴ were obtained first from diethyl tartrate in good yield.The oxidative scission of Ⅴ by periodic acid gave glycoxylic amides Ⅵ,which were then nitroethylated immediately without working up and produce 2-hydroxy-3-nitrobutyric amide Ⅶ catalyzed by KF-alumina.The nitro group of Ⅶ was then reduced by Zn+NH4Cl or Zn+NH4Cl+catalytic amount of 10%Pd-C to yield 2-hydroxy-3-aminobutyric amide Ⅶ,and followed by formylation of the amino group to give 2-hydroxy-3-formamidobutyric amide Ⅴ.With the occurrence of H2/Pd-C and ethyl formic ester,the reduction of the nitro group and the formylation of the amino group could be finished in one step.By this way three isocyanide formers were synthesized with the R group benzyl,cyclohexyl and 2-cyclohexenylethyl respectively.

Solid-phase Synthesis of Azidomethylene Inhibitors Targeting Cysteine Proteases.

Fused Bicyclic Caspase‐1 Inhibitors Assembled by Copper‐Free Strain‐Promoted Alkyne–Azide Cycloaddition (SPAAC)

Synthesis of Hydroxyethylene-based β-Secretase Inhibitors

Asymmetric Synthesis of γ-Amino-Functionalised Vinyl Sulfones: De Novo Preparation of Cysteine Protease Inhibitors

Identification of Dihydropyrazolo[1,5-a]pyrazin-4(5H)-ones as Cyclic Products of β-Amidomethyl Vinyl Sulfone Alphavirus Cysteine Protease Inhibitors

Diaminodiacid-based solid-phase synthesis of peptide disulfide bond mimics.

New peptide deformylase inhibitors design, synthesis and pharmacokinetic assessment

Template Synthesis of CPP32 Inhibitors by Ugi Four-Component Condensation Reaction

Azole reagents enabled ligation of peptide acyl pyrazoles for chemical protein synthesis

Identification of Dihydropyrazolo[1,5-a]pyrazin-4(5H)-ones as Cyclic Products of Beta-Amidomethyl Vinyl Sulfone Alphavirus Cysteine Protease Inhibitors

Ionic immobilization, diversification, and release: application to the generation of a library of methionine aminopeptidase inhibitors

Biosynthetic characterization and combinatorial biocatalysis of the cysteine protease inhibitor E-64

Synthesis of A Peptidomimetic Hcmv Protease Inhibitor Library

Simple, Enantiocontrolled Azetidine Library Synthesis via Strain Release Functionalization of 1-Azabicyclobutanes

The Study on HCMV Protease Inhibitors (I) Design and Liquid-phase Combinatorial Building Block Synthesis of Peptidomimetic Inhibitors

Efficient Synthesis of Terminal Α,β-Unsaturated Ketones As the Intermediates of the Proteasome Epoxyketone Inhibitors Via Weinreb Amide

Solid-Phase Synthesis of 2-Pyridones, 1,4-Diazepines, and 1,4-Oxazepines from Resin-Bound 3-Amino-2-seleno Ester

Selective Peptide Cysteine Manipulation on Demand and Difficult Protein Chemical Synthesis Enabled by Controllable Acidolysis of N,S‐Benzylidene Thioacetals

Fragment-Based Design and Synthesis of Symmetrical bis -Peptidotriazoles Using Alkylidene bis -Amide Formations and Subsequent Triazole Ligation with β-Acetamido Carbonyl Scaffolds

Chemical Synthesis of Proteins Using an o -Nitrobenzyl Group as a Robust Temporary Protective Group for N-Terminal Cysteine Protection

Robust Synthesis of C-terminal Cysteine-Containing Peptide Acids Through a Peptide Hydrazide-Based Strategy.